Incidence of Invasive Group A Streptococcus Infection in Relation to the COVID-19 Pandemic (GASCO) - A Pilot Study
Files
Description
Group A Streptococcus (GAS) is a known cause of invasive infections in humans leading to significant morbidity and mortality. During the COVID-19 pandemic the incidence of respiratory infections had decreased, likely due to pandemic interventions. Previous studies found a correlation between the rates of viral respiratory infections and a predisposition to invasive GAS infections (iGAS). We hypothesize that the incidence of iGAS among adults may have been affected by the COVID-19 pandemic, but evidence is lacking. GASCO compares the rate of iGAS infections before, during and after the COVID-19 pandemic, and evaluates factors that may affect the incidence and outcomes. In this pilot study, we describe the incidence of total GAS infection (tGAS) and iGAS in relation to the COVID-19 pandemic.
Publication Date
5-9-2025
Disciplines
Internal Medicine
Recommended Citation
Stremers J, Bray H, Caulfield A, Fulmer R, Ciochetto Z, Simeunovic G. Incidence of invasive group A streptococcus infection in relation to the COVID-19 pandemic (GASCO) - A pilot study. Presented at: Research Day Corewell Health West; 2025 May 9; Grand Rapids, MI.
Comments
2025 Research Day Corewell Health West, Grand Rapids, MI, May 9, 2025. Abstract 1746